Physician profile
Robert A Mccready
NPI 1558380931
$2,963.92
in general payments reported to CMS, 2019-2025
22 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $191 · 2021: $740 · 2022: $445 · 2023: $337 · 2024: $136 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $419.12 | 2021-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $381.23 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Angiodynamics, INC. | $379.18 | 2019-2023 | Alphavac |
| Philips North America LLC | $265.75 | 2019-2024 | (6554) Peripheral Vascular Undivided, (Bh4) Igt Devices Undivided |
| Lemaitre Vascular, INC. | $209.89 | 2019-2021 | |
| Medtronic Vascular, INC. | $200.29 | 2019-2020 | |
| Abbott Laboratories | $193.91 | 2021-2023 | Amplatzer Talisman |
| Janssen Pharmaceuticals, INC | $142.29 | 2019-2021 | |
| Penumbra, INC. | $138.15 | 2022 | |
| Janssen Scientific Affairs, LLC | $124.63 | 2022 | |
| Endologix LLC | $123.82 | 2019 | |
| Covidien Lp | $78.24 | 2019 | |
| Cardiovascular Systems INC. | $68.77 | 2022 | |
| Terumo Medical Corporation | $57.71 | 2022-2025 | Glidewire, Azur Cx Detachable |
| Mallinckrodt Enterprises LLC | $47.66 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $37.42 | 2020 | |
| Atricure, INC. | $27.60 | 2019 | |
| Advanced Respiratory, INC | $16.58 | 2019 | |
| Elutia, INC. | $14.71 | 2019 | |
| Tactile Systems Technology INC | $14.50 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.45 | 2019 | |
| Pfizer INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mccready listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.